Niranjan Y. Sardesai

2018

In 2018, Niranjan Y. Sardesai earned a total compensation of $1.3M as Former Chief Operating Officer at Inovio Pharmaceuticals, a 9% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$171,238
Option Awards$358,612
Salary$448,101
Stock Awards$354,783
Other$15,250
Total$1,347,984

Sardesai received $448.1K in salary, accounting for 33% of the total pay in 2018.

Sardesai also received $171.2K in non-equity incentive plan, $358.6K in option awards, $354.8K in stock awards and $15.3K in other compensation.

Rankings

In 2018, Niranjan Y. Sardesai's compensation ranked 7,683rd out of 14,244 executives tracked by ExecPay. In other words, Sardesai earned more than 46.1% of executives.

ClassificationRankingPercentile
All
7,683
out of 14,244
46th
Division
Manufacturing
2,985
out of 5,759
48th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
371
out of 849
56th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
210
out of 547
62nd
Industry
Surgical and Medical Instruments and Apparatus
129
out of 348
63rd

Pay ratio

Niranjan Y. Sardesai's Pay$1,347,984
Median Employee's Pay$118,696
Pay Ratio

11

to 1

In 2018, the annual total compensation of Niranjan Y. Sardesai was $1,347,984.

The annual total compensation of the median employee at Inovio Pharmaceuticals was $118,696.

The ratio of Niranjan Y. Sardesai's pay to the pay of median employee was therefore 11 to one.

Source: SEC filing on March 25, 2019.

Sardesai's colleagues

We found three more compensation records of executives who worked with Niranjan Y. Sardesai at Inovio Pharmaceuticals in 2018.

2018

J Kim

Inovio Pharmaceuticals

Chief Executive Officer

2018

Mark Bagarazzi

Inovio Pharmaceuticals

Chief Medical Officer

2018

Peter Kies

Inovio Pharmaceuticals

Chief Financial Officer

News

You may also like